[HTML][HTML] Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez, A Nascimento… - Orphanet journal of rare …, 2012 - Springer
Abstract Background Between 8% and 22% of female carriers of DMD mutations exhibit
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
[PDF][PDF] Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez, A Nascimento… - 2012 - researchgate.net
Abstract Background: Between 8% and 22% of female carriers of DMD mutations exhibit
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
[PDF][PDF] Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez, A Nascimento… - 2012 - Citeseer
Abstract Background: Between 8% and 22% of female carriers of DMD mutations exhibit
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
[HTML][HTML] Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez… - Orphanet Journal of …, 2012 - ncbi.nlm.nih.gov
Background Between 8% and 22% of female carriers of DMD mutations exhibit clinical
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodriguez, A Nascimento… - Orphanet Journal of …, 2012 - go.gale.com
Background Between 8% and 22% of female carriers of DMD mutations exhibit clinical
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez… - Orphanet journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Between 8% and 22% of female carriers of DMD mutations exhibit clinical
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan Mateu, MJ Rodríguez, A Nascimento… - Orphanet Journal of …, 2012 - diposit.ub.edu
Background: Between 8% and 22% of female carriers of DMD mutations exhibit clinical
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
symptoms of variable severity. Development of symptoms in DMD mutation carriers without …
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.
J Juan-Mateu, MJ Rodríguez… - Orphanet Journal of …, 2012 - search.ebscohost.com
Abstract Background: Between 8% and 22% of female carriers of DMD mutations exhibit
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
[PDF][PDF] Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez, A Nascimento… - 2012 - cyberleninka.org
Abstract Background: Between 8% and 22% of female carriers of DMD mutations exhibit
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
[PDF][PDF] Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
J Juan-Mateu, MJ Rodríguez, A Nascimento… - 2012 - academia.edu
Abstract Background: Between 8% and 22% of female carriers of DMD mutations exhibit
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …
clinical symptoms of variable severity. Development of symptoms in DMD mutation carriers …